Literature DB >> 10654279

In vivo assessment of synovial microcirculation and leukocyte-endothelial cell interaction in mouse antigen-induced arthritis.

A Veihelmann1, A G Harris, F Krombach, E Schütze, H J Refior, K Messmer.   

Abstract

OBJECTIVE: The microcirculation and leukocyte-endothelial cell interaction in synovial tissue of an inflamed joint are known to play a crucial role in the pathogenesis of rheumatoid arthritis. The aim of this study was to characterize the in vivo changes in the microvasculature and in leukocyte-endothelial cell interactions in the mouse synovial tissue using intravital fluorescence microscopy in three stages of antigen-induced arthritis. The expression of E- and P-selectin and ICAM-1 were also studied using immunohistochemistry.
METHODS: Antigen-induced arthritis (AiA) was produced in Balb/c mice. The severity of arthritis at three different phases was quantified using a clinical and histological score. For the intravital fluorescence microscopy measurements, the patella tendon was partially resected for visualization of the intraarticular synovial tissue of the knee joint. The number of rolling and adherent leukocytes, functional capillary density (FCD) and RBC velocity were quantitatively measured in synovial microvessels. Expression of ICAM-1, E- and P-selectin was assessed by immunohistochemistry.
RESULTS: There was a significant increase in the leukocyte rolling fraction in postcapillary venules in the acute phase of AiA (from 0.26 +/- 0.05 in controls to 0.45 +/- 0.04 8 d after AiA induction). The number of leukocytes adherent to the endothelium was significantly elevated in all phases of arthritis (from 121 +/- 27 in controls to 376 +/- 62 mm2 63 d after AiA-induction). Functional capillary density was significantly enhanced in the acute (332 +/- 15 cm/cm2) and intermediate phases (320 +/- 15 cm/cm2) compared to control values (227 +/- 15 cm/cm2). Arthritis resulted in a distinct increase in the expression of ICAM-1 on the synovial endothelium in all phases of AiA. E- and P-selectin expression were detected only in the acute phase.
CONCLUSION: Our model provides new insights into the microcirculatory changes which occur in the synovial tissue of an arthritic joint.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10654279

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  6 in total

1.  Opioid control of inflammatory pain regulated by intercellular adhesion molecule-1.

Authors:  Halina Machelska; Shaaban A Mousa; Alexander Brack; Julia K Schopohl; Heike L Rittner; Michael Schafer; Christoph Stein
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

2.  Distinct in vivo roles of CD80 and CD86 in the effector T-cell responses inducing antigen-induced arthritis.

Authors:  Dragana Odobasic; Michelle T Leech; Jin R Xue; Stephen R Holdsworth
Journal:  Immunology       Date:  2008-01-24       Impact factor: 7.397

3.  Gene expression profile and synovial microcirculation at early stages of collagen-induced arthritis.

Authors:  Philip Gierer; Saleh Ibrahim; Thomas Mittlmeier; Dirk Koczan; Steffen Moeller; Jürgen Landes; Georg Gradl; Brigitte Vollmar
Journal:  Arthritis Res Ther       Date:  2005-05-17       Impact factor: 5.156

Review 4.  Insights Into Leukocyte Trafficking in Inflammatory Arthritis - Imaging the Joint.

Authors:  Julia E Manning; Jonathan W Lewis; Lucy-Jayne Marsh; Helen M McGettrick
Journal:  Front Cell Dev Biol       Date:  2021-03-09

Review 5.  In vivo imaging approaches in animal models of rheumatoid arthritis.

Authors:  Michael L Dustin
Journal:  Arthritis Res Ther       Date:  2003-05-01       Impact factor: 5.156

6.  Local Biological Reactions and Pseudotumor-Like Tissue Formation in relation to Metal Wear in a Murine In Vivo Model.

Authors:  Alexander C Paulus; Kathrin Ebinger; Xiangyun Cheng; Sandra Haßelt; Patrick Weber; J Philippe Kretzer; Rainer Bader; Sandra Utzschneider
Journal:  Biomed Res Int       Date:  2019-10-29       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.